Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/tetrahydroxycortisone ratio and 11β-hydroxyandrosterone

Clinical Chemistry

Volumn 58, Issue 4, 2012, Pages 741-747

  Koyama, Yuhei ^a,b   Homma, Keiko ^c   Fukami, Maki ^d   Miwa, Masayuki ^a   Ikeda, Kazushige ^a   Ogata, Tsutomu ^d   Hasegawa, Tomonobu ^a   Murata, Mitsuru ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c KEIO UNIVERSITY HOSPITAL   (Japan)

^d NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5ALPHA TETRAHYDROXYCORTISONE; 5BETA TETRAHYDROXYCORTISONE; ANDROSTENEDIONE; ANDROSTERON 11BETA OL; HYDROCORTISONE; PRASTERONE; PREGNANETRIOLONE; UNCLASSIFIED DRUG;

ARTICLE; CLASSIC 21 HYDROXYLASE DEFICIENCY; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; HUMAN; INFANT; JAPANESE; MALE; MASS FRAGMENTOGRAPHY; P450 OXIDOREDUCTASE DEFICIENCY; STEROID BLOOD LEVEL; TRANSIENT HYPER 17ALPHA HYDROXYPROGESTERONEMIA;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL HYPERPLASIA, CONGENITAL; ANDROSTERONE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFANT; INFANT, NEWBORN; MALE; NADPH-FERRIHEMOPROTEIN REDUCTASE; PREGNANETRIOL; STEROID 17-ALPHA-HYDROXYLASE; STEROID 21-HYDROXYLASE; TETRAHYDROCORTISONE;

EID: 84859341835     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.173286     Document Type: Article

References (20)

1. Nimkarn S, Lin-Su K, New MI. Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2009;38:699-718.
2. Miller WL. P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations. Trends Endocrinol Metab 2004;15:311-5. (Pubitemid 39180005)
3. Fukami M, Hasegawa T, Horikawa R, Ohashi T, Nishimura G, Homma K, Ogata T. Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis. Pediatr Res 2006;59:276-80. (Pubitemid 43841002)
4. Stewart PM. The adrenal cortex. In: Larsen PR, Kronenberg HM, Melrned S, Polonsky KS (eds). Williams textbook of endocrinology, 10th ed. Philadelphia: Saunders; 2002. p 491-551.
5. Homma K, Hasegawa T, Takeshita E, Watanabe K, Anzo M, Toyoura T, et al. Elevated urine pregnanetriolone definitively establishes the diagnosis of classical 21-hydroxylase deficiency in term and preterm neonates. J Clin Endocrinol Metab 2004;89:6087-91. (Pubitemid 39628418)
6. Shackleton C, Marcos J, Malunowicz EM, Szarras-Czapnik M, Jira P, Taylor NF, et al. Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis. Am J Med Genet A 2004;128:A223-31.
7. Fukami M, Nishimura G, Homma K, Nagai T, Hanaki K, Uematsu A, et al. Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients. J Clin Endocrinol Metab 2009;94:1723-31.
8. Homma K, Hasegawa T, Masumoto M, Takeshita E, Watanabe K, Chiba H, et al. Reference values for urinary steroids in Japanese newborn infants: gas chromatography/mass spectrometry in selected ion monitoring. Endocr J 2003;50:783-92. (Pubitemid 38139964)
9. Caulfield MP, Lynn T, Gottschalk ME, Jones KL, Taylor NF, Malunowicz EM, et al. The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. J Clin Endocrinol Metab 2002;87:3682-90. (Pubitemid 34879513)
10. Wudy SA, Hartmann MF. Gas chromatographymass spectrometry profiling of steroids in times of molecular biology. Horm Metab Res 2004;36:415-22. (Pubitemid 38932100)
11. Shackleton CH, Honour JW, Taylor NF. Metabolism of fetal and neonatal adrenal steroids. J Steroid Biochem 1979;11:523-9. (Pubitemid 9245927)
12. Wilson JD, Auchus RJ, Leihy MW, Guryev OL, Estabrook RW, Osborn SM, et al. 5alpha-Androstane-3alpha,17beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha,17alpha-diol-20-one as a key intermediate. Endocrinology 2003;144:575-80. (Pubitemid 36205230)
13. Homma K, Hasegawa T, Nagai T, Adachi M, Horikawa R, Fujiwara I, et al. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone. J Clin Endocrinol Metab 2006;91:2643-9. (Pubitemid 44024631)
14. New MI. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006;91:4205-14. (Pubitemid 44833386)
15. Kashimada K, Ono M, Onishi T, Koyama S, Toyoura T, Imai K, et al. Clinical course of patients with nonclassical 21-hydroxylase deficiency (21-OHD) diagnosed in infancy and childhood. Endocr J 2008;55:397-404. (Pubitemid 351670968)
16. Custodio RJ, Junior CE, Milani SL, Simões AL, de Castro M, Moreira AC. The emergence of the cortisol circadian rhythm in monozygotic and dizygotic twin infants: the twin-pair synchrony. Clin Endocrinol (Oxf) 2007;66:192-7. (Pubitemid 46096137)
17. Miller WL, Huang N, Agrawal V, Giacomini KM. Genetic variation in human P450 oxidoreductase. Mol Cell Endocrinol 2009;300:180-4.
18. Fukami M, Horikawa R, Nagai T, Tanaka T, Naiki Y, Sato N, et al. Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocrinol Metab 2005;90:414-26. (Pubitemid 40116690)
19. Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, et al. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 2005;76:729-49. (Pubitemid 40563096)
20. Dhir V, Ivison HE, Krone N, Shackleton CH, Doherty AJ, Stewart PM, Arlt W. Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P. Mol Endocrinol 2007;21:1958-68. (Pubitemid 47173803)